close
close

Cytokinetics presents new data on the safety and long-term use of Aficamten at the European Society of Cardiology Congress 2024

Posted on by Vaseline
Cytokinetics presents new data on the safety and long-term use of Aficamten at the European Society of Cardiology Congress 2024

Data from integrated safety analysis of three clinical studies
Aficamten’s Enhanced Robust Safety Profile

Analysis of FOREST-HCM shows successful
Withdrawal of standard care medicines
in patients with obstructive HCM treated with Aficamten

Related Posts

It contains superfood

It contains superfood

If the Verdauung begins, while Abnehmen helps and Bluthochdruck vorbeugen: Chiasamen gilts as healthy. Everything for the Superfoods and the eighth best test. Do you […]

Stalin is zurück

Stalin is zurück

If you click on “Accept”, you can transfer your data and information (zB by Cookies) to Ihrem Endgerät, bzw. grifen op diese zu. Die V…